ADVANZ PHARMA Corp. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$626.2M

Net Income/Loss (FY2017)

-$1.6B

Total Assets (FY2017)

$2.3B

Total Equity (FY2017)

-$1.9B

Cash Flows from Operating Activities (FY2017)

$283.2M

Source: ADVANZ PHARMA Corp. 20-F filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.